 Study design: This study is a multicenter controlled randomized clinical trial Allogeneic cord blood platelet gel CBPG vs Standard local medications SLM. Each clinical centre has been invited to enroll 15 treated and 15 control patients, according to local availability in the 12 month study interval. 